Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms

Molecular and Cellular Biochemistry

Volumn 195, Issue 1-2, 1999, Pages 199-206

  Stepanova, Victoria ^a   Mukhina, Svetlana ^a   Köhler, Eleonore ^b   Resink, Thérese J ^b   Erne, Paul ^b,c   Tkachuk, Vsevolod A ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c LUZERNER KANTONSSPITAL   (Switzerland)

Author keywords

Human smooth muscle cell; Isoforms; Migration; Proliferation; Urokinase

Indexed keywords

APROTININ; DNA; PLASMIN; RECOMBINANT PROTEIN; UROKINASE; UROKINASE RECEPTOR;

AMINO TERMINAL SEQUENCE; AORTA; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; ISOTOPE LABELING; PROTEIN DEGRADATION; PROTEIN DOMAIN; SMOOTH MUSCLE FIBER;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CELL DIVISION; CELL MOVEMENT; DNA; ENZYME PRECURSORS; GLYCOSYLATION; HUMANS; HYDROLYSIS; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; MUTAGENESIS, SITE-DIRECTED; PEPTIDE HYDROLASES; PLASMIN; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0033016886     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006936623106     Document Type: Article

References (34)

1. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nilesen LS, Skriver L: Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44: 139-266, 1985
2. Clowes AW, Clowes MM, Au YPT, Reidy MA, Belin D: Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res 67: 61-67, 1990
3. Lupu F, Heim DA, Bachmann F, Hurni M, Kakkar VV, Kruithof EKO: Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 15: 1444-1445, 1995
4. Goldsmith GJ, Ziats NP, Robertson AJ: Studies on plasminogen activator and other proteases in subcultured human vascular cells. Exp Mol Pathol 35: 257-264, 1981
5. Wang W, Chen HJ, Gieddi KN, Schwartz A, Cannon PJ: T-cell lymphokines, imterleukin-4 and gamma interferon, modulate the induction of smooth muscle cell tissue plasminogen activator and migration by serum and platelet-derived growth factor. Circ Res 77: 1095-1106, 1995
6. Okada SS, Grobmeyer SR, Barnathan ES: Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion. Arterioscler Thromb Vasc Biol 16: 1269-1276, 1996
7. Jackson CL, Reidy MA: The role of plasminogen activation in smooth muscle cell migration after arterial injury. Ann NY Acad Sci 667: 141-150, 1992
8. Clowes AW, Clowes MM, Kirkman TR, Jackson CL, Au YP, Kenagy R: Heparin inhibits the expression of tissue-type plasminogen activator by smooth muscle cells in injured rat carotid artery. Circ Res 70: 1128-1136, 1992
9. Busso N, Masur SK, Lazega D, Waxman S, Ossowski L: Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J Cell Biol 126: 259-270, 1994
10. Resnati M, Guttinger M, Valcamonica S, Sidenius N, Blasi F, Fazioli F: Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. Embo J 15: 1572-1582, 1996
11. Herbert JM, Lamarche I, Prabonnaud V, Dol F, Gauthier T: Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells. J Biol Chem 269: 3076-3080, 1994
12. He CJ, Rebibou JM, Peraldi MN, Meulders Q, Rondeau E: Growth factor-like effect of urokinase type plasminogen activator in human renal cells. Biochem Biophys Res Commun 176: 1408-1416, 1991
13. Rabbani SA, Desjardins J, Bell AW, Banville D, Mazar A, Henkin J, Goltzman D: An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells. Biochem Biophys Res Commun 173: 1058-1064, 1990
14. De Petro G, Copeta A, Barlati S: Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts. Exp Cell Res 213: 286-294, 1994
15. Rabbani SA, Mazar AP, Bernier SM, Haq M, Bolivar I, Henkin J, Goltzman D: Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J Biol Chem 267: 14151-14156, 1992
16. Shetty S, Kumar A, Johnson A, Pueblitz S, Idell S: Urokinase receptor in human malignant mesothelioma cells: Role in tumor cell mitogenesis and proteolysis. Am J Physiol 268: L972-L982, 1995
17. Belogurov AA, Bibilashvili RS, Goryunova LE, Delver EP, Domkin VV, Efimov ED, Rybalkin IN, Savochkina LP, Sidorov MA, Skamrov AV, Chenchik AA, Shevlev AY, Yuzhakov AA: Patent No. 1692151, 1993
18. Stepanova V, Bobik A, Bibilashvily R, Belogurov A, Rybalkin I, Domogatsky S, Little PJ, Goncharova E, Tkachuk V: Urokinase plasminogen activator induces smooth muscle cell migration: Key role of growth factor-like domain. FEBS Lett 414: 417-474, 1997
19. Scott-Burden T, Resink TJ, Hahn AWA, Baur U, Box R, Bnohler FR. Induction of growth-related metabolism in human vascular smooth muscle cells by low density lipoprotein. J Biol Chem 264: 12582-12589, 1989
20. Skinner MP, Raines EW, Ross R: Dynamic expression of alpha 1 beta 1 and alpha 2 beta 1 integrin receptors by human vascular smooth muscle cells. Alpha 2 beta 1 integrin is required for chemotaxis across type I collagen-coated membranes. Am J Pathol 145: 1070-1081, 1994
21. Blasi F, Vassalli J-D, Dano K: Urokinase-type plasminogen activator: proenzyme, receptor and inhibitors. J Cell Biol 104: 801-804, 1987
22. Reuning U, Bang NU: Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens. Arterioscler Thromb 12: 1161-1170, 1992
23. Hamon M, Bauters C, McFadden EP, Wernert N, Lablanche JM, Dupuis B, Bertrand ME: Restenosis after coronary angioplasty. Eur Heart J 16(suppl 1): 33-48, 1995
24. Reidy M: Regulation of arterial smooth muscle cell growth In: SM Schwartz, RP Mecham (eds). The Vascular Smooth Muscle Cell: Molecular and Biological Responses to the Extracellular Matrix. Academic Press, 1995, pp 271-295
25. Carmeliet P, Collen D: Gene targeting and gene transfer studies of the plasminogen/plasmin system: implications in thrombosis, hemostasis, neointima formation, and atherosclerosis. Faseb J 9: 934-938, 1995
26. Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeier W, Daikuhara Y, Tsubouchi H, Blasi F, Comoglio PM: Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. Embo J 11: 4825-4833, 1992
27. Saksela O, Rifkin DB: Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator- mediated proteolytic activity. J Cell Biol 110: 767-775, 1990
28. Fibbi G, Ziehe M, Morbidelli L, Magnelli L, Del RM: Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells [published erratum appears in Exp Cell Res 1990 Jan; 186(1):196]. Exp Cell Res 179: 385-95, 1988
29. Anichini E, Fibbi G, Pucci M, Caldini R, Chevanne M, Del RM. Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor. Exp Cell Res 213: 438-448, 1994
30. Gudewicz PW, Gilboa N: Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils. Biochem Biophys Res Commun 147: 1176-1181, 1987
31. Del Rosso M, Anichini E, Pedersen N, Blasi F, Fibbi G, Pucci M, Ruggiero M: Urokinase-urokinase receptor interaction: Non-mitogenic signal transduction in human epidermal cells. Biochem Biophys Res Commun 190: 347-52, 1993
32. Gyetko MR, Todd RR, Wilkinson CC, Sitrin RG: The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest 93: 1380-1387, 1994
33. Higazi AA, Upson RH, Cohen RL, Manuppello J, Bognacki J, Henkin J, McCrae KR, Kounnas MZ, Strickland DK, Preissner KT, Lawler J, Cines DB: Interaction of single-chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins. Blood 88: 542-551, 1996
34. Behrendt N, Ploug M, Patthy L, Houen G, Blasi F, Dano K: The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator. J Biol Chem 266: 7842-7847, 1991